Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness and persistence of acitretin, ciclosporin, fumaric acid esters and methotrexate for patients with moderate-to-severe psoriasis: a cohort study from BADBIR.
Alabas OA, Mason KJ, Yiu ZZN, Hampton PJ, Reynolds NJ, Owen CM, Bewley A, Laws PM, Warren RB, Lunt M, Smith CH, Griffiths CEM; BADBIR Study Group. Alabas OA, et al. Among authors: mason kj. Br J Dermatol. 2023 Apr 20;188(5):618-627. doi: 10.1093/bjd/ljad004. Br J Dermatol. 2023. PMID: 36763783
Estimating the direct healthcare utilization and cost of musculoskeletal pain among people with comorbidity: a retrospective electronic health record study.
Png ME, Mason KJ, Marshall M, Jordan KP, Bailey J, Frisher M, Heron N, Huntley AL, Mallen CD, Mamas MA, Tatton S, White S, Edwards JJ, Achana F. Png ME, et al. Among authors: mason kj. Curr Med Res Opin. 2023 Oct 19:1-8. doi: 10.1080/03007995.2023.2271862. Online ahead of print. Curr Med Res Opin. 2023. PMID: 37853741
Pre-existing musculoskeletal pain and its association with mortality in newly diagnosed co-morbid conditions: an electronic health record cohort study.
Marshall M, Mason KJ, Edwards JJ, Mamas MA, Bailey J, Heron N, Achana FA, Frisher M, Huntley AL, Mallen CD, Png ME, Tatton S, White S, Jordan KP. Marshall M, et al. Among authors: mason kj. Rheumatol Adv Pract. 2023 Nov 24;8(1):rkad104. doi: 10.1093/rap/rkad104. eCollection 2024. Rheumatol Adv Pract. 2023. PMID: 38089500 Free PMC article.
The association of age at psoriasis onset and HLA-C*06:02 with biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).
Alabas OA, Mason KJ, Yiu ZZN, Warren RB, Dand N, Barker JN, Smith CH, Griffiths CEM; BADBIR and BSTOP study group. Alabas OA, et al. Among authors: mason kj. Br J Dermatol. 2024 Apr 17;190(5):689-700. doi: 10.1093/bjd/ljad481. Br J Dermatol. 2024. PMID: 38051972
The impact of the COVID-19 pandemic on referrals to musculoskeletal services from primary care and subsequent incidence of inflammatory rheumatic musculoskeletal disease: an observational study.
Burton C, Bajpai R, Mason KJ, Bailey J, Jordan KP, Mallen CD, Welsh VK. Burton C, et al. Among authors: mason kj. Rheumatol Adv Pract. 2023 May 2;7(2):rkad044. doi: 10.1093/rap/rkad044. eCollection 2023. Rheumatol Adv Pract. 2023. PMID: 37251663 Free PMC article.
Effectiveness and survival of methotrexate versus adalimumab in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).
Alabas OA, Mason KJ, Yiu ZZN, Warren RB, Lunt M, Smith CH, Griffiths CEM; BADBIR Study Group. Alabas OA, et al. Among authors: mason kj. Br J Dermatol. 2023 Aug 24;189(3):271-278. doi: 10.1093/bjd/ljad179. Br J Dermatol. 2023. PMID: 37226927 Clinical Trial.
48 results